LeMaitre Vascular, Inc. LMAT
$81.93
-0.24%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $114.50
- Implied Upside
- +39.8%
- Price Target Range
- $94.00 – $127.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-05 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $104 → $94 |
| 2026-06-03 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $120 |
| 2026-05-06 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $105 → $120 |
| 2026-05-06 | CitizensDaniel Stauder |
Maintains | Market outperform | $118 → $127 |
| 2026-05-06 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $94 → $104 |
| 2026-02-26 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $95 → $105 |
| 2026-02-26 | Roth CapitalKyle Bauser |
Reiterates | Buy | $108 → $117 |
| 2026-02-26 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $87 → $94 |
| 2026-02-26 | CitizensDaniel Stauder |
Maintains | Market outperform | $113 → $118 |
| 2026-02-20 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $95 |
| 2025-11-07 | Wells FargoNathan Treybeck |
Maintains | Equal-weight | $97 → $93 |
| 2025-11-05 | Roth CapitalKyle Bauser |
Reinstates | Buy | $108 |
| 2025-10-15 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $95 |
| 2025-09-23 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $95 |
| 2025-08-06 | Cantor FitzgeraldRoss Osborn |
Maintains | Neutral | $92 → $95 |
| 2025-08-06 | Barrington ResearchMichael Petusky |
Upgrades | Market perform → Outperform | $95 |
| 2025-07-22 | Barrington ResearchMichael Petusky |
Reiterates | Market perform | — |
| 2025-02-28 | Lake StreetBrooks O'Neil |
Maintains | Buy | $105 → $110 |
| 2025-02-28 | Citizens Capital MarketsDaniel Stauder |
Maintains | Buy | $105 → $110 |
| 2025-02-28 | Barrington ResearchMichael Petusky |
Downgrades | Outperform → Market perform | — |
| 2025-02-13 | Wells FargoNathan Treybeck |
Initiates coverage on | Equal-weight | $95 |
| 2024-11-01 | OppenheimerSuraj Kalia |
Reiterates | Outperform | $90 → $93 |
| 2024-11-01 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $92 → $93 |
| 2024-10-15 | Cantor FitzgeraldRoss Osborn |
Initiates coverage on | Neutral | $96 |
| 2024-09-20 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $92 |
| 2024-08-20 | JMP SecuritiesDaniel Stauder |
Maintains | Market outperform | $77 → $100 |
| 2024-08-02 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $79 → $82 |
| 2024-05-31 | Roth MKMJason Wittes |
Reinstates | Buy | $100 |
| 2024-05-03 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $69 → $79 |
| 2024-05-03 | JMP SecuritiesDaniel Stauder |
Maintains | Market outperform | $72 → $77 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $81.93
- Market Cap
- $1.88 billion
- 52-Week Range
- $78.65 – $118.01
- Average Volume
- 377K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.